Research has shown that AGG interruption analysis can help us provide you and your patients who are found to be fragile X premutation carriers with a more refined reproductive risk. [1, 2]
A higher number of AGG interruptions is associated with a lower risk of expansion. By counting the number of AGG repeats present, we can help refine the risk of a woman having a child affected with fragile X syndrome. [1, 2]
Counsyl is excited to announce that we are now offering AGG interruption analysis for select fragile X orders. 
Graph adapted from: www.fragilexcarrier.com
Applicable to ~1 in 200 women tested:*
1. Patients identified with 55-90 CGG repeats for fragile X syndrome will automatically receive AGG interruption analysis via Asuragen. There will be no additional charge for this feature.
2. A preliminary Foresight™ Carrier Screen report will be issued within the normal two week turnaround time with Fragile X CGG repeat results and an final report will be issued within 3 weeks of the preliminary report with the results of the AGG interruption analysis.
3. AGG interruption analysis can not be performed on saliva samples. If a saliva sample returns with 55-90 CGG repeats, a secondary blood collection kit will be sent to your clinic in order to complete AGG analysis.
*Based on internal data
An updated informed consent form is necessary to cover this analysis. Log into counsyl.com/healthcare to access this updated form.
Note: AGG interruption analysis is not available for international orders
Questions? Contact email@example.com or reach out directly to your Counsyl representative.
December 23, 2020
Myriad’s 7 Greatest Hits in 2020
Before we say goodbye to 2020, we’d like to thank and recognize our partners. Together, we ensure patients have access…Read more about Myriad’s 7 Greatest Hits in 2020
December 4, 2020
Knowledge is Power: How PKU Affected the Ahern Family
December 3rd is National PKU Day. PKU, short for phenylketonuria, is an inherited genetic condition in which the body cannot properly…Read more about Knowledge is Power: How PKU Affected the Ahern Family
November 3, 2020
Simplify Patient Identification
Streamlining Cancer Risk Assessment with Digital Tools November is Family Health History Month and is a good time to bring…Read more about Simplify Patient Identification